Big Pharma may threaten to cut S.Africa investment in generics row
January 17, 2014 at 00:23 AM EST
JOHANNESBURG, Jan 17 (Reuters) - Global drug firms may threaten to cut their South African investments as part of a campaign against Pretoria's plans to overhaul its intellectual property laws to favour generic production, documents seen by Reuters show.
